{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Significant leverage (3x daily)",
            "Daily compounding effect on returns",
            "Implied synthetic replication using derivatives (swaps likely)",
            "Explicit comprehension alert in KID ('not simple and may be difficult to understand')",
            "Intended for sophisticated investors only",
            "Highest risk rating (7/7)",
            "Short recommended holding period (1 day) due to compounding"
        ],
        "classification": "complex",
        "supporting_data": "The product is identified as 'Leverage Shares 3x Square ETP Securities', which immediately flags it as a non-UCITS Exchange Traded Product (ETP), thus negating the UCITS presumption of non-complexity. Its primary objective is to provide '3 times the value of the daily performance' of an equity security. This significant daily leverage (3x) necessitates the use of derivatives (such as total return swaps or futures) as an integral part of its investment strategy to achieve its objective, rather than merely for efficient portfolio management. The KID's description of 'underlying assets... held in the margin account' and 'Collateral Assets' further indicates an indirect, synthetic or collateralized structure typical of derivative-based products. The document explicitly highlights the 'Compounding Effect', which means holding the product for more than one day will result in returns significantly different from 3 times the underlying asset's performance over that period, making its long-term payoff structure difficult for a retail investor to understand. This is a key indicator of complexity, as is the 'Recommended holding period: 1 day'. The KID itself includes a mandatory 'comprehension alert' stating: 'You are about to purchase a product that is not simple and may be difficult to understand', which is a direct confirmation of its complex classification under MiFID II. It also explicitly targets 'sophisticated investors' who 'understand the risk of compounded returns and the increased risk of investment in leveraged products', indicating it is not suitable for an average retail investor with basic knowledge. The product's risk indicator is 'class 7 out of 7', the highest risk class. All these factors align with the MiFID II rules and ESMA guidance, which classify products with significant leverage, derivative-dependent strategies, opaque structures, and features difficult for average retail investors to comprehend (like compounding effects) as complex (CESR/09-295 Section I, paragraph 7 and Section V, paragraphs 107-108; ESMA35-36-1640 Paragraph 19)."
    }
}